Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease

American Journal of Transplantation

Volumn 13, Issue 2, 2013, Pages 363-368

  Heimbach, J K ^a   Watt, K D S ^a   Poterucha, J J ^a   Ziller, N Francisco ^a   Cecco, S D ^a   Charlton, M R ^a   Hay, J E ^a   Wiesner, R H ^a   Sanchez, W ^a   Rosen, C B ^a   Swain, J M ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Bariatric surgery; liver transplantation; metabolic syndrome; obesity; sleeve gastrectomy; weight gain

Indexed keywords

ANTIBIOTIC AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ABSCESS DRAINAGE; ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BODY MASS; CLINICAL ARTICLE; DIABETES MELLITUS; END STAGE LIVER DISEASE; FATTY LIVER; FEMALE; FOLLOW UP; GRAFT DYSFUNCTION; HUMAN; LIVER ABSCESS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; OPERATION DURATION; PRIORITY JOURNAL; SLEEVE GASTRECTOMY; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; AGED; BODY MASS INDEX; ENDOSCOPY; FEMALE; GASTRECTOMY; GASTRIC BYPASS; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84873083982     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04318.x     Document Type: Article

References (20)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL,. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497.
2. Wawrzynowicz-Syczewska M, Karpińska E, Jurczyk K, Laurans L, Boroń-Kaczmarska A,. Risk factors and dynamics of weight gain in patients after liver transplantation. Ann Transplant 2009; 14: 45-50.
3. Leonard J, Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M., The impact of obesity on long-TERM outcomes in liver transplant recipients-Results of the NIDDK Liver Transplant Database. Am J Transplant 2008; 8: 667-672.
4. Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steato-hepatitis in the United States. Gastroenterology 2011; 141: 1249-1253.
5. Thuluvath PJ, Guidinger MK, Fung JJ, et al. Liver transplantation in the United States. Am J Transplant 2010; 10: 1003-1019.
6. Nair S, Vanatta JM, Arteh J, Eason JD,. Effects of obesity, diabetes, and prior abdominal surgery on resource allocation in liver transplantation: a single center study. Liver Transpl 2009; 15: 1519-1524.
7. Contos MJ, Cales W, Sterling RK, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001; 7: 363-373.
8. Dureja P, Mellingerr J, Agni R, et al. NAFLD recurrence in liver transplant recipients. Transplantation 2011; 91: 684-668.
9. Gane EJ,. Diabetes Mellitus following liver transplantation in patients with hepatitis C virus: Risks and consequences. Am J Transplant 2012; 12: 531-538.
10. Watt K, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR,. Evolution of causes and risk factors for mortality post liver transplant: Results of the NIDDK long term follow-up study. Am J Transplant 2010; 10: 1-8.
11. Weingarten TN, Swain JM, Kendrick ML, et al. Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery. Obes Surg 2011; 21: 1714-1720.
12. Mosko JD, Nguyen GC,. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol 2011; 9: 897-901.
13. D'Hondt M, Vanneste A, Pottel, et al. Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surg Endosc 2011; 25: 2498-2504.
14. Butte J, Devaud N, Jarufe NP, et al. Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation. Obes Surg 2007; 17: 1517-1519.
15. Duchini A, Brunson ME,. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity. Transplantation 2001; 72: 156-159.
16. Gentileschi P, Venza M, Benavoli D, et al. Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: A case report. Obes Surg 2009; 19: 1460-1463.
17. Tichansky DS, Madan AK,. Laparoscopic Roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation. Obes Surg 2005; 15: 1481-1486.
18. Rogers CC, Alloway RR, Alexander JW, et al. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: A pilot study. Clin Transplant 2008; 22: 281-291.
19. Campsen JZM, Shoen J, Wachs M, et al. Adjustable gastric banding in a morbidly obese patient during liver transplantation. Obes Surg 2008; 18: 1625-1627.
20. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK,. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: A prospective, double blind study. Ann Surg 2008; 247: 401-407.